Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection
Clinical trial NCT04488575 · TERMINATED
Trial details
- NCT number
- NCT04488575
- Sponsor
- Evelo Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2021-05-16
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.